Hims & Hers Health, Inc. (NYSE: HIMS) reported Q3 EPS of ($0.08), $0.02 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $74.2 million versus the consensus estimate of $70.53 million.

GUIDANCE:

Hims & Hers Health, Inc. sees Q4 2021 revenue of $76-78 million, versus the consensus of $70.13 million.

For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.